The findings in our study are consistent with previous reports as we found that the LAMA3, LAMB3, and LAMC2 genes were upregulated in patients with PAAD, with hazard ratios of 3.86, 2.18, and 3.06, respectively. This evidence concerns the gene LAMB3 and pancreatic adenocarcinoma.